Specialties

Rheumatology

Conferences Earn CME/CE

More Conferences

Featured CME/CE Activities

More CME Activities

Click for Credit Free CME/CE

‘Real-world’ study finds treat-to-target benefits out to 5 years

DAS28 and HAQ scores improved in patients with early RA in daily clinical practice.

Immunogenicity concerns for biosimilars so far don’t go beyond originator biologics

But there are few data available on the impact of antidrug antibodies to biosimilars across rheumatic diseases and on switching.

Survival in lupus patients has plateaued

Wealthier countries have generally fared better than low- and middle-income countries.

Oral contraceptive use linked to lower rheumatoid arthritis risk

The decrease in risk was seen only in women with ACPA-positive RA.

More Click for Credit

Conference News & Video

Psoriasis duration reflects cardiovascular event risk

For every year of psoriasis, a patient’s risk of a major cardiovascular event climbs an additional 1%.

Is PASI 100 the new benchmark in psoriasis?

KAUAI, HAWAII – “I think we should just do away with PASI 90 and look at how well our drugs do against the metric of PASI 100.”

How to avoid severe diarrhea from apremilast

Delayed up-titration of apremilast is often effective, albeit at cost of slower efficacy.

More Conference News & Video

Scientific Abstracts

There are no results under this Specialty.

More Scientific Abstracts